Showing 1 - 3 results of 3 for search 'David Gil-Ortega', query time: 0.02s Refine Results
  1. 1
    Efectividad y seguridad en nuestro entorno de adalimumab como tratamiento anti-TNF de primera linea en niños con enfermedad de Crohn

    Efectividad y seguridad en nuestro entorno de adalimumab como tratamiento anti-TNF de primera linea en niños con enfermedad de Crohn by Víctor Manuel Navas-López, Gemma Pujol Muncunill, Enrique Llerena, María Navalón Rubio, David Gil-Ortega, Vicente Varea-Calderón, Carlos Sierra Salinas, Javier Martin-de-Carpi

    Published 2018-02-01
    Get full text
    Article
  2. 2
    A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for paediatric Crohn's disease

    A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for paediatric Crohn's disease by Víctor Manuel Navas-López, Gemma Pujol-Muncunill, Enrique Llerena, María Navalón Rubio, David Gil-Ortega, Vicente Varea-Calderón, Carlos Sierra Salinas, Javier Martin-de-Carpi

    Published 2018-02-01
    Get full text
    Article
  3. 3
    Direct percutaneous endoscopic jejunostomy in pediatric age with a pexies triangulation system: report of a case and literature review

    Direct percutaneous endoscopic jejunostomy in pediatric age with a pexies triangulation system: report of a case and literature review by Fernando Alberca-de-las-Parras, María Navalón-Rubio, Juan Egea-Valenzuela, Francisco-Javier Álvarez-Higueras, Gonzalo Antón-Ródenas, Miriam Alajarín-Cervera, Andrés Serrano-Giménez, David Gil-Ortega, María Muñoz-Tornero, Akiko Ono-Ono, Luis Fernando Carballo-Álvarez

    Published 2015-04-01
    Get full text
    Article

Search Tools: